Aspen Pharmacare (OTCMKTS:APNHY – Get Free Report) was the recipient of a significant decrease in short interest in the month of June. As of June 15th, there was short interest totaling 1,032 shares, a decrease of 34.3% from the May 31st total of 1,571 shares. Currently, 0.0% of the shares of the company are sold short. Based on an average daily volume of 609 shares, the days-to-cover ratio is currently 1.7 days.
Aspen Pharmacare Stock Performance
OTCMKTS:APNHY opened at $9.41 on Friday. Aspen Pharmacare has a 12 month low of $5.24 and a 12 month high of $9.41. The company has a debt-to-equity ratio of 0.36, a current ratio of 3.64 and a quick ratio of 2.66. The company’s 50 day moving average is $8.69 and its 200-day moving average is $7.83.
Aspen Pharmacare Company Profile
Aspen Pharmacare Holdings Limited is a multinational pharmaceutical company headquartered in Durban, South Africa. Founded in 1997 by Stephen Saad and Gus Attridge, Aspen has grown from a regional generic drug producer into a global specialist in branded and generic medicines. The company is publicly traded on the Johannesburg Stock Exchange and its American depositary receipts trade over‐the‐counter under the symbol APNHY.
Aspen’s core business encompasses the development, manufacture and distribution of a broad portfolio of injectable and oral pharmaceutical products.
Featured Articles
- Five stocks we like better than Aspen Pharmacare
- Why Kroger’s Giant Eagle Deal Could Change Everything
- Why the Comcast Spin-Off Won’t Fix What’s Actually Broken
- Shorting the Grid: Bloom Energy’s $25B AI Power Play
- SanDisk’s Volatility May Be Telling Bulls What They Want to Hear
Receive News & Ratings for Aspen Pharmacare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspen Pharmacare and related companies with MarketBeat.com's FREE daily email newsletter.
